Pavesio Alessandra 4
4 · Bioventus Inc. · Filed Apr 5, 2022
Insider Transaction Report
Form 4
Pavesio Alessandra
SVP & Chief Science Officer
Transactions
- Exercise/Conversion
Class A Common Stock
2022-04-01+61,476→ 181,306 total - Exercise/Conversion
Restricted Stock Units
2022-04-01−61,476→ 0 total→ Class A Common Stock (61,476 underlying) - Sale
Class A Common Stock
2022-04-04$11.17/sh−32,997$368,425→ 148,309 total
Footnotes (4)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.
- [F2]Reflects shares sold to cover taxes upon the vesting of RSUs on April 1, 2022 pursuant to a standing 10b5-1 instruction.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.12 to $11.28, inclusive. Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F4]The RSUs vested on April 1, 2022.